SARA OBRINGER: Open Payments
NPI 1376301465 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,175 in 207 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $818 · 2025 $3,175
Food & beverage: $3,046Education: $129
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 40 | $566 |
| ABBVIE INC. | 35 | $555 |
| Otsuka America Pharmaceutical, Inc. | 34 | $447 |
| Teva Pharmaceuticals USA, Inc. | 19 | $444 |
| Vanda Pharmaceuticals Inc. | 29 | $371 |
| Alkermes, Inc. | 9 | $216 |
| Janssen Pharmaceuticals, Inc | 11 | $195 |
| Lundbeck LLC | 18 | $172 |
| E.R. Squibb & Sons, L.L.C. | 5 | $110 |
| Axsome Therapeutics, Inc. | 3 | $50 |
Products named: INGREZZA, VRAYLAR, REXULTI, FANAPT, ARISTADA, UZEDY, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
